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Mitral valves, including the papillary muscles, were harvested from freshly 
slaughtered sheep and implanted in 10 recipient growing sheep. A strip of 
ovine pericardium was used to reinforce the anulus and a patch of expanded 
polytetrafluoroethylene was used to cover the donor papillary muscle. In four 
valves the natural chordae tendineae at the anterior cusp were supported by 
two pairs of 5-0 expanded polytetrafluoroethylene sutures. At the beginning of 
the experiment two animals died early of valve incompetence. Another animal 
had to be put to death because of paraplegia fter extracorporeal circulation 
and one died on postoperative day 41 of endocarditis. Six sheep were electively 
put to death, five after 153 - 8 days and one after 43 days. At the time of 
follow-up, a complete hemodynamic study including echocardiography and 
stress testing was performed. Heart rate at rest was 91 - 14 beats/min, left 
ventricular systolic pressure 96 - 20 mm Hg, left ventricular end-diastolic 
pressure 11 -4-- 5 mm Hg, cardiac output 2.04 - 0.40 L/min, and the mean 
transvalvular p essure gradient was 4.9 - 2.8 mm Hg as measured by cardiac 
catheterization. Echocardiography showed excellent movement of all valve 
components. However, minor regurgitation was evident in one case. Gross 
morphologic haracteristics showed good healing at the anulus and host 
papillary muscle; in one case there was a rupture of one small first-order 
chorda. On radiography no signs of calcification were evident. Light micros- 
copy revealed minor to moderate collagen degeneration i  all valve compo- 
nents. However, on electron microscopy the presence of numerous fibroblasts 
within the long-term implants indicated the biosynthesis of new collagen. In 
summary, allograft mitral valve replacement seems to be a promising proce- 
dure if the chordae tendineae are reinforced by expanded polytetrafluoroeth- 
ylene sutures. (J THORAC CARDIOVASC SURG 1996;111:595-604) 
p reservation of the mitral valve should be pre- 
ferred to avoid mitral valve replacement with me- 
chanical or bioprosthetic valves. Left ventricular func- 
tion improves if the continuity between the papillary 
muscle and leaflet is preserved in such operations. 1' 2 
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However, in only 20% to 30% of patients undergoing 
mitral valve operations can a valve reconstruction be 
performed. As in aortic valve operations, cryopre- 
served allografts might be expected to be the ideal 
substitutes in mitral valve replacement. Because of the 
complexity of the mitral valve apparatus (anulus, leaf- 
lets, chordae tendineae, papillary muscles), replace- 
ment of the diseased valve with a mitral allograft has 
been attempted previously in only a few patients, and 
with limited long-term success. 3'4 Rupture of the 
chordae tendineae was the principal cause of mitral 
incompetence. 
An experimental study was designed to evaluate the 
in vivo function and the long-term durability of a trans- 
planted allograft mitral valve in a growing sheep mod- 
el. For the purpose of reinforcing the natural chordae 
tendineae of the allograft, artificial chordae made 
from expanded polytetrafluoroethylene (ePTFE) su- 
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Fig. 1. Stentless allograft mitral implant including artificial chordae of ePTFE suture at the anterior leaflet. 
tures were applied to the mitral implant. Such ePTFE 
chordae were first used experimentally in 19845 and 
have since been applied successfully as chordal substi- 
tutes in many patients. 6-s 
Material and methods 
Allograft preparation. Complete mitral valves, includ- 
ing the mitral anulus, the papillary muscles, and the 
chordae tendineae, were excised from the hearts of freshly 
slaughtered sheep weighing between 30 and 35 kg. A strip 
of untreated ovine pericardium from the same donor sheep 
was used to reinforce the natural valve anulus (Fig. 1). A 
patch, 0.4 mm thick, consisting of ePTFE,* was used to cover 
the tips of the papillary nmscle of the donor graft. This patch 
was sutured to the truncated papillary muscles with a 5-0 
ePTFE suture. In four implants the same suture was woven 
through the anterior leaflet and knotted at the annular site to 
reinforce the natural chordae tendineae. The internal diam- 
eter of the donor mitral valves ranged between 25 and 29 
mm. For the in vivo studies, allografts of 23 mm and 25 mm 
internal diameter were manufactured to match the size of 
the recipient mitral anulus. Therefore the anulus of the 
donor mitral valve had to be reduced. 
Several species of microorganisms were detected on 
microbiologic examination of the harvested valves. Listed 
by decreasing frequency of occurrence, they were Staph- 
ylococcus epidermidis, Escherichia coli, Corynebacterium 
sp., Bacteroides fragilis, Candida blastomyces, and Acineto- 
bacter. After this examination, the stentless implant was 
rinsed with Ringer's solution and incubated for 24 hours 
at 4 ° C in an antibiotic solution containing a mixture of 
ciprofloxacin, amikacin, vancomycin, metronidazol, and 
amphotericin B. Valves were stored at 4°C (Earle me- 
dium 199) and implanted within 2 weeks. Swabs were 
*Gore-Tex cardiovascular patch, registered trademark of W. L. 
Gore & Associates, Inc., Elkton, Md. 
taken frequently for microbiologic examination. Only 
sterile valves were used for long-term animal studies. 
Operative technique. Implantation of the stentless al- 
lograft mitral valves was performed in 10 female growing 
sheep (Orne Biotechnologies Inc., New Hope, Pa.) with a 
mean body weight of 22 to 26 kg. The animals were 
anesthetized with pentobarbital 2 mg/kg, intubated, and 
then supported with a respirator; anesthesia was main- 
tained by administration of an oxygen-nitrous oxide mix- 
ture and halothane. Heart rate was monitored by a 
standard electrocardiogram. The heart was exposed 
through a left thoracotomy in the fourth intercostal space. 
After systemic heparinization (1mg/kg), eardiopulmonary 
bypass was established by cannulation of the left femoral 
artery for arterial perfusion and cannulation of the right 
atrial appendage for venous return. Mitral valve trans- 
plantation was performed with the heart beating; no 
cardioplegic solution was used. A left atriotomy was 
carried out and the native mitral valve was completely 
excised, including the tips of the papillary muscles. After 
sizing of the annular ring, the appropriate allograft im- 
plant was chosen. Two mattress utures (4-0 polypro- 
pylene) armed with Teflon pledgets were placed at the site 
of the host's anterior and posterior papillary muscles and 
then returned through the ePTFE patch of the implant. 
Tying down these four sutures drew the mitral implant 
into place. The anulus was sewn with a continuous 5-0 
polypropylene suture. Valve competence was tested by in- 
jecting saline solution into the left ventricle. Air was evacu- 
ated from the beating heart and the atriotomy was closed. 
After removal of the perfusion cannulas, the heparin effect 
was reversed with protamine sulfate and the chest was 
closed. Morphine was given intramuscularly to relieve post- 
operative pain. For postoperative infectious prophylaxis, 
gentamicin (2 mg/kg per day) and cefamandole (75 mg/kg 
per day) were given intramuscularly for 10 days. 
All animals received humane care in compliance with 
the "Principles of Laboratory Animal Care" formulated 
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by the National Society for Medical Research and the 
"Guide for the Care and Use of Laboratory Animals" 
prepared by the Institute of Laboratory Animal Resources 
and published by the National Institutes of Health (NIH 
Publication No. 86-23, revised 1985). 
Long-term follow-up. The sheep were frequently exam- 
ined for signs of heart failure (breathing rate, ascites, heart 
murmur) and maintained at the animal institute until they 
were electively put to death. At that time the sheep were 
anesthetized as described earlier. A Swan-Ganz catheter 
(Baxter Healthcare Corp. Edwards Div., Santa Ana, Calif.) 
was introduced through the right jugular vein for measure- 
ment of central venous pressure, pulmonary artery pressure, 
pulmonary artery wedge pressure, and cardiac output. Aortic 
pressure was obtained by catheterization f the left carotid 
artery, and left ventricular pressure and left ventricular 
end-diastolic pressure were measured via a Mikro-Tip ma- 
nometer (Millar Instruments Inc., Houston, Tex.) placed in 
the left ventricular cavity through the right carotid artery. 
Left atrial pressure was obtained by cannulation of a pulmo- 
nary vein. Measurements were taken at rest and after stress 
load with a continuous infusion of norepinephrine, 1/xg/kg 
per minute. The effective orifice area was calculated with a 
modified Gorlin formula. All parameters are given as means 
_+ standard eviation. 
In addition, epicardial echochardiography and pulsed 
Doppler studies were performed (model 77020A, 2.5 
MHz transducer, Hewlett-Packard Company, Andover, 
Mass.) before the final hemodynamic studies. Experi- 
ments were terminated by intravenous injection of potas- 
sium chloride. The hearts were dissected and macro- 
scopically examined. Roentgenograms (mammography 
technique) of all specimens were taken at 26 keV/6.3 mA 
to determine calcific deposits. 
Areas of interest of the specimen were fixed in 4% 
formaldehyde and processed for histologic examination with 
a light microscope. Samples were stained with hematoxylin- 
eosin and elastica-van Gieson stains. For electron examina- 
tion with an microscope, small segments of the specimen 
were immediately fixed in 2.5% glutaraldehyde buffered with 
cacodylate 0.1 mol/L, pH 7.4, postfixed with 1% osmium 
tetroxide in the same buffer, then dehydrated in an alcohol 
series. Transmission electron microscopy was performed 
with a Zeiss 900 electron microscope (Zeiss, Jena, Germa- 
ny). For scanning electron microscopy, the specimens were 
critical point dried with carbon dioxide, mounted, coated 
with gold-palladium, and observed with a Jeol T20 scanning 
electron microscope (Jeol, Peadbody, Mass.). 
Results 
All 10 animals urvived the surgical procedure. At 
the beginning of the study two sheep died early on the 
second and ninth postoperative days, respectively, 
because of valve incompetence. The reason in the first 
case was surgically related (twisting of a papillary 
muscle). Rupture of a central chorda at the anterior 
leaflet was identified at autopsy in the second case; in 
addition, an atrial septal defect had been closed by 
direct suture at the time of allograft implantation in 
this sheep. One animal died of endocarditis 7 weeks 
after mitral valve implantation. Another sheep had 
paraplegia of the back legs after the surgical proce- 
dure. This animal was anesthetized and catheter and 
echocardiographic studies were performed, which 
showed no signs of mitral incompetence or stenosis. 
The animal was put to death and the mitral implant 
was found to be intact. The result was that six sheep 
were able to be put to death electively, five sheep after 
158 _+ 8 days and one after only 43 days. The mean 
body weight at the time of death was 32.0 _+ 2.8 kg. A 
23 mm valve was implanted in five animals and a 25 
mm valve in one. 
Itemodynamic study. At follow-up the average 
heart rate at rest was 91 + 14 beats/min, increasing 
during exercise to 131 __ 25 beats/min. Left ventricular 
pressure rose from 96 _+ 20 to 133 _+ 38 mm Hg; left 
ventricular end-diastolic pressure was 11 _+ 5 mm Hg 
at rest and 10 _+ 2 mm Hg during stress test. The 
average cardiac output increased from 2.04 _+ 0.50 
L/rain to 3.38 _+ 1.09 L/min. The mean mitral valve 
gradient was 4.9 _+ 2.8 mm Hg on average at baseline 
measurements and rose to 8.1 + 4.5 mm Hg during 
norepinephrine infusion. Calculated effective orifice 
area was 1.01 _+ 0.59 cm 2 versus 1.39 _+ 0.60 cm 2. 
Echocardiography. Two-dimensional echocardi- 
ography of the left ventricular short axis showed full 
simultaneous opening of the anterior and posterior 
cusps throughout the cardiac ycle. The long-axis view 
revealed a correct anatomic valve position and good 
attachment of the subvalvular apparatus with chordae 
tendineae under continuous tension. Epicardial two- 
dimensional echocardiography at the end of follow-up 
revealed competent valves with minor regurgitation 
only in one valve and unchanged marginal overlapping 
(Fig. 2, A and B). Complete echocardiographic data 
have been published recently. 9 
Gross morphologic features (Table I). All mitral 
allografts howed good healing of the anulus and of 
the papillary muscle (Figs. 3 and 4). The leaflets and 
the natural chordae were pliable without signs of 
calcification. However, in one specimen a first-order 
chorda (free-edge chorda) was thinned and in another 
case a first-order chorda had ruptured at the anterior 
leaflet. The last valve was the one that showed minor 
regurgitation (grade I) on echocardiography. Neither 
valve was chordally supported. No chordal ruptures 
occurred at the papillary muscles. In the four valves in 
which artificial ePTFE chordae were added, all natural 
chordae were intact. In three of these valves the 
ePTFE chordae were covered by a thin smooth tissue; 
in the fourth valve, however, the artificial chordae 
were thinned and lacked flexibility at the papillary 
muscle site, and one single suture was ruptured. The 
ePTFE patches at the papillary muscle sites were all 
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Fig. 2. Two-dimensional echocardiogram (left ventricular long axis) during systole (A) and diastole (B) of a 
stentless, chordally supported allograft mitral valve 154days after implantation. LA, Left atrium; LV,, left 
ventricle. 
covered by fibrous tissue and had healed well to the 
host tissue. 
Radiographic examination of the explanted valves 
revealed no significant signs of calcification within 
the anulus, the leaflets, and the chordae tendineae 
(see Table I, Fig. 5). However, the artificial, ePTFE 
chordae were calcified in one case on x-ray exami- 
nation. 
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Table I. Gross morphologic and histologic haracteristics of explanted stentless mitral allografis 
Anulus Leaflets Chordae tendineae ePTFE chordae* Papillary muscle 









None (n = 4); 








Natural pliability, Pliable, normal Pliable (n = 3), 
no tissue appearance (n = 4); fibrous overgrowth; 
overgrowth first-order chordae calcification 
thinned (n = 1) (n = 1, with 
and ruptured (n - 1) rupture of a 
at leaflet site; single suture) 
good healing at 
papillary muscle site 
None (n = 5); None None (n = 3); 
minimal (n = 1) minimal (n - 1) 
Fibrous layer: Not done 
minimal (n : 4) 
Collagen 
degeneration: 
minimal (n - 2); 




(n = 1); minimal 
(n = 2); moderate 





minimal (n = 6) 







None (n = 4); 
minimal (n = 2) 
Fibrosis: moderate 
(n = 3); severe 
(n = 3) 






*Implanted in four animals, four chordae ach, 
His to log ic  resul ts .  The histologic results revealed 
by light microscopy are summarized in Table I. Good 
healing of the allograft both to the anulus and to the 
papillary muscle was found (Fig. 6). A thin fibrous 
overgrowth was detected at the site of the anulus, the 
leaflets, and the natural chordae tendineae. The 
ePTFE patch was completely covered by fibrous tissue 
in all cases. Necrosis of the donor papillary muscle and 
replacement by scar tissue were evident (Fig. 6, B). In 
two valves the atrial myocardium of the donor was 
fibrotic at the allograft anulus. A chronic inflammatory 
reaction (macrophages, granulocytes) was seen in two 
explanted valves within the leaflets at the site of 
annular attachment. This reaction was more evident 
within the papillary muscles. However, the chordae 
tendineae showed no signs of an inflammatory infiltra- 
tion. 
Transmission electron microscopy revealed collage- 
nous structures ranging from well-organized fibrils to 
loose bundle formation to areas of complete lysis. 
Occasional electron dense, presumably calcareous, de- 
posits were found to be attached to the collagen fibrils 
(Fig. 7). Elastic fibers with broad peripheral zones of 
microfibrils have been observed frequently. Numerous 
active fibroblasts could be found within the leaflets and 
the chordae tendineae. These fibroblasts howed a 
well-developed rough endoplasmic reticulum, a eu- 
chromatin-rich nucleus, and numerous extensions. 
Several fibroblasts were surrounded by a fairly dense 
layer of collagen fibrils (Fig. 8). A complete denuda- 
tion of the cardial endothelium was detected by scan- 
ning electron microscopy. Both leaflets and chordae 
tendineae were covered by a regularly shaped layer of 
fibrous tissue. The ePTFE chordae were almost com- 
pletely covered by fibrous tissue. Occasional fibroblasts 
could be detected. 
Discuss ion  
Experimental studies are the basis for significant 
new surgical methods before they are applied in pa- 
tients. During this study, case reports on the use of 
homograft mitral valves in patients were published by 
other investigators. In 1993, Pomar and Mestres w 
reported on tricuspid valve replacement with a mitral 
homograft. Acar and associates 11 published the use of 
a cryopreserved homograft for mitral valve replace- 
ment in 1994. Despite the report on chordal rupture 
during the follow-up by Sievers and coworkers, 4 no 
"design" changes were suggested from these investiga- 
tors. Partial replacement of the anterior mitral cusp 
with cryopreserved allografts was successfully per- 
formed in sheep by Revuelta's group. 12 A stentless and 
chordally supported bovine pericardial mitral prosthe- 
sis underwent successful experimental testing by Liao, 
Wuu, and FraterJ 3 
In our experimental design we applied some signif- 
icant modifications to the native allograft mitral valve 
to reinforce the anulus, the chordae tendineae, and the 
papillary muscles. In preliminary experiments, we used 
"nonmodified" mitral homografts in a series of sheep. 
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Fig. 3. Explanted mitral valve allograft 156 days after implantation. Good healing at the anulus and at the 
papillary muscle is evident. Cusps and chordae tendineae are pliable without signs of fibrosis. However, 
some chordae tendineae appear thinned (arrow). No artificial chordae had been used in this mitral implant. 
Because of leaflet rupture at the annular side and 
tearing of chordae at the site of the papillary muscles, 
resulting in early death, we did modify the homograft 
valve. No late deaths occurred during follow-up as a 
result of failure of any of the components ofthe mitral 
apparatus comprising the allograft implant. Reinforce- 
ment of the mitral anulus with autologous pericardium 
had a purpose, because the mitral valve of sheep is 
rather fragile. Because the donor sheep were heavier 
(about 35 kg) than the recipient sheep (22 to 26 kg), 
we had to reduce the anulus of the donor mitral valve 
to an internal diameter of 23 mm and 25 mm to 
facilitate implantation i to the recipient sheep. This 
allowed the appositional area of the mitral allograft 
implant o increase, allowing more flexibility in valve 
adjustment during the implant procedure. In some 
cases the donor papillary muscles had to be sewn along 
side the remaining recipient papillary muscles to avoid 
prolapse. Therefore the whole mitral implant was 
rotated 5 to 10 mm. 
The finding of thinned chordae tendineae among 
normally appearing chordae might indicate different 
areas of stress of implanted allografts. Early clinical 
results of the use of a stentless porcine mitral valve 
substitute introduced by Vrandecic and colleagues 14
in 1992 revealed chordal rupture as a major prob- 
lem. Morea and associates 15reported on three early 
valve failures from rupture of first-order chordae in 
a group of seven patients. The use of ePTFE suture 
as a substitute for chordae tendineae has been 
investigated experimentally s and recently advocated 
clinically in a 7-year follow-up of 106 patients by 
Zussa and coworkers,  In our study, however, in one 
case we found calcification of the ePTFE sutures. 
The preimplantation treatment and storage of the 
stentless allograft mitral implant in our study might 
have had a negative ffect on the artificial material, 
which caused a rupture in one case. The histologic 
investigation could not clarify the mechanism of the 
rupture of the ePTFE chorda. Nevertheless, we are 
convinced that the use of ePTFE chordae is the 
most suitable approach for reinforcement and re- 
placement of chordae tendineae at present. 
Good healing in the recipient, partly the result of 
foreign-body reaction to the ePTFE patch, was found 
at the papillary muscle site. The vigorous fibrous 
overgrowth including the origin of the natural chordae 
tendineae was able to strengthen that "weak" site. As 
a result, no chordal rupture was detected at the site of 
the papillary muscles at follow-up. 
The histologic hanges in the explanted allografts 
showed a minor to moderate degree of collagen 
degeneration. However, all valves were still pliable 
without evidence of major calcification, although 
occasional small calcifications could be seen. Valve 
function was not impaired by these changes. The 
most significant finding of this experimental study 
was the appearance of active fibroblasts within the 
transplanted allograft issue. These fibroblasts were 
observed more frequently near the tissue surface. 
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Fig. 4. Specimen explanted after 154 days. All valve components are well preserved and pliable. The 
artificial ePTFE suture chordae showed good healing to the anterior leaflet, and they were able to protect 
the natural chordae tendineae from thinning and from rupture. Arrow, ePTFE suture. 
Fig. 5. Radiograph of a stentless mitral allograft implanted for 158 days showing no signs of calcification 
in the area of leaflets and chordae tendineae. A, Mitral valve anulus; PM, papillary muscle. 
These cells dearly originate from the host and invade 
the donor tissue. The packed, relatively thin collagen 
fibrils (immature fibrils?) surrounding many of these 
active fibroblasts uggest production of new collagen 
by host-mediated cells. In fact, this has always been the 
hope with homografts but, to our knowledge, has not 
yet been seen with homograft aortic valves. Turnover 
and resorption of collagen are essential for efficient 
wound healing and for the maintenance of structural 
integrity in load-bearing and pressure-bearing organ 
systemsJ 6 In some areas of the valvular tissue indica- 
tions for the beginning of calcification were found (Fig. 
7). However, in the growing sheep model 5 to 6 
months after implantation, we would expect rather 
more severe calcific changes as seen after implantation 
of bioprosthetic xenograftsJ 7' 18 
When glycerol-treated autologous pericardium was 
used for chordal replacement in sheep, not only was 
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Fig. 6. Light microscopy of a specimen implanted for 158 days. A, Histologic aspect of the transplanted 
valve with interspersed atrial fat cells (Fc) and occasional residual fibroblactic stroma cells (Sc). No 
inflammatory infiltration is apparent. (Hematoxylin-eosin tain; original magnification ×30.) B, Histologic 
section through the papillary muscle. Note the ePTFE patch (P), focal necrosis (N) of the donor muscle, 
fibrosis (Fi), and isolated areas of chronic inflammatory infiltration (Ci). Ct, chordae tendineae. 
(Elastica-van Gieson stain; original magnification ×20.) 
the implanted pericardium covered by host tissue, but 
also the host tissue was remodeled, apparently in 
response to functional requirements of the implantJ 9
In our experience, the growing sheep model seems 
most suitable for the investigation of new cardiac 
bioprostheses. Implantation periods of 5 to 6 months 
are sufficient for evaluation of valve behavior and for 
detection of long-term morphologic changes. 
Because we were not able to harvest sterile donor 
valves, antibiotic sterilization was necessary. The neg- 
ative effects, especially of amphotericin B, on the 
endothelium of porcine aortic valves have previously 
been investigated by Feng and associates. 2° In our 
opinion, the sacrifice of an extra animal to receive a 
sterile allograft mitral valve was not justified for the 
purpose of this investigation. It can be suggested that 
the use of cryopreserved allografts should produce 
even better long-term results in an animal study. 
The Journal of Thoracic and 
Cardiovascular Surgery 
Volume 111, Number 3 
Vetter et al. 603 
Fig. 7. Transmission electron micrograph of the anterior leaflet of an allograft mitral valve implanted for 
132 days. Areas of organized collagen bundles (Co) and areas showing loose formations of elatic fibers (El) 
are present. The dark spots might represent the onset of calcification (arrow). (Original magnification 
×33,000.) 
Fig. 8. Transmission electron micrograph of the anterior mitral leaflet from a specimen implanted for 158 
days showing a fibroblast. A eucromatic nucleus (Nc) and the dense area of collagen fibrils (asterisks) 
around it could be aform of immature collagen suggesting cellular activity. (Original magnification ×5600.) 
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The hemodynamic  per formance of the stentless 
and chordal ly supported allograft mitral implant was 
very satisfactory at follow-up. The animals had normal 
hemodynamic function at rest. Transvalvular pressure 
gradients were not elevated if the valve was competent 
after implantation. A physiologic response to stress 
was observed during norepinephrine infusion. The 
effective orifice areas calculated uring the hemody- 
namic study are rather low. This observation might be 
due to the formula because, to our knowledge, there 
are no data on body surface area in sheep. Therefore 
effective orifice area was calculated by means of a 
formula usually applied in human beings. 
Echocardiographic  examinat ion revealed good 
movement  of all valve components.  In addit ion, in 
vitro studies of the stentless, chordal ly supported 
sheep mitral  valve revealed significantly lower trans- 
valvular gradients and significantly larger effective 
orifice areas than those of porcine bioprostheses of
the same internal diameter.  21 
In summary, this exper imental  study confirms the 
possibil ity of mitral  valve transplantat ion with good 
hemodynamic  and echocardiographic valve charac- 
teristics. However,  satisfactory long-term results can 
be expected only if the prob lem of a possible chordal  
rupture during a reparat ive phase of col lageneous 
structures can be solved. Encouraged by excellent 
clinical results, the use of ePTFE  suture for rein- 
forcement of the natural  chordae seems to be the 
most suitable approach. 
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